1. Home
  2. BEAM vs CRTO Comparison

BEAM vs CRTO Comparison

Compare BEAM & CRTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BEAM
    SELLHOLDBUYas of 17 hours ago
  • CRTO
    SELLHOLDBUYas of 17 hours ago
  • Stock Information
  • Founded
  • BEAM 2017
  • CRTO 2005
  • Country
  • BEAM United States
  • CRTO France
  • Employees
  • BEAM N/A
  • CRTO N/A
  • Industry
  • BEAM Biotechnology: Biological Products (No Diagnostic Substances)
  • CRTO Advertising
  • Sector
  • BEAM Health Care
  • CRTO Consumer Discretionary
  • Exchange
  • BEAM Nasdaq
  • CRTO Nasdaq
  • Market Cap
  • BEAM 2.3B
  • CRTO 2.1B
  • IPO Year
  • BEAM 2020
  • CRTO 2013
  • Fundamental
  • Price
  • BEAM $19.53
  • CRTO $35.41
  • Analyst Decision
  • BEAM Strong Buy
  • CRTO Buy
  • Analyst Count
  • BEAM 11
  • CRTO 10
  • Target Price
  • BEAM $50.50
  • CRTO $54.67
  • AVG Volume (30 Days)
  • BEAM 2.5M
  • CRTO 331.4K
  • Earning Date
  • BEAM 05-06-2025
  • CRTO 05-01-2025
  • Dividend Yield
  • BEAM N/A
  • CRTO N/A
  • EPS Growth
  • BEAM N/A
  • CRTO 115.91
  • EPS
  • BEAM N/A
  • CRTO 1.90
  • Revenue
  • BEAM $63,518,000.00
  • CRTO $1,933,289,000.00
  • Revenue This Year
  • BEAM N/A
  • CRTO N/A
  • Revenue Next Year
  • BEAM $6.32
  • CRTO $7.82
  • P/E Ratio
  • BEAM N/A
  • CRTO $18.43
  • Revenue Growth
  • BEAM N/A
  • CRTO N/A
  • 52 Week Low
  • BEAM $18.30
  • CRTO $33.15
  • 52 Week High
  • BEAM $35.25
  • CRTO $49.93
  • Technical
  • Relative Strength Index (RSI)
  • BEAM 31.67
  • CRTO 40.54
  • Support Level
  • BEAM $21.60
  • CRTO $34.53
  • Resistance Level
  • BEAM $22.97
  • CRTO $38.48
  • Average True Range (ATR)
  • BEAM 1.70
  • CRTO 1.48
  • MACD
  • BEAM -0.36
  • CRTO 0.11
  • Stochastic Oscillator
  • BEAM 12.07
  • CRTO 32.53

Stock Price Comparison Chart: BEAM vs CRTO

BEAM
CRTO
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober20250102030405060708090100110120130140BEAM VS CRTO

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing. The company's pipeline programs consist of BEAM-101, ESCAPE, BEAM-302, BEAM-301, and BEAM-201.

About CRTO Criteo S.A.

Criteo SA is an ad-tech company in the digital advertising market. Its technology, allows retailer advertisers to launch multichannel and cross-device marketing campaigns in real time. With real-time return on investment analysis of the ads, the firm's clients can adjust their marketing strategies dynamically. The firm also provides technology allowing retailers to effectively manage their ad inventories and improve yield optimization.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use